Barriers to accrual and enrollment in brain tumor trials.

• Lee, Eudocia Quant Dana-Farber Cancer Institute, Boston, MA;
• Chukwueke, Ugonma Nnenna Massachusetts General Hospital, Boston, MA;
• Hervey-Jumper, Shawn L. University of California, San Francisco, San Francisco, CA;
• De Groot, John Frederick The University of Texas MD Anderson Cancer Center, Houston, TX;
• Leone, Jose Pablo Dana-Farber Cancer Institute, Boston, MA;
• Armstrong, Terri S. The University of Texas Health Science Center School of Nursing, Houston, TX;
• Chang, Susan Marina University of California, San Francisco, San Francisco, CA;
• Arons, David National Brain Tumor Society, Newton, MA;
• Oliver, Kathy Rose International Brain Tumor Alliance, Surrey, United Kingdom;
• Galanis, Evanthia Mayo Clinic, Rochester, MN;
• Friday, Bret Edward Buckley SMDC, Duluth, MN;
• Lin, Nancy U. Dana-Farber Cancer Institute, Boston, MA;
• Mehta, Minesh P. Miami Cancer Institute, Baptist Health South Florida, Miami, FL;
• Penas-Prado, Marta The University of Texas MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX;
• Vogelbaum, Michael A. Cleveland Clinic, Cleveland, OH;
• Sahebjam, Solmaz Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL;
• Van Den Bent, Martin J. Erasmus MC Cancer Centre, Rotterdam, Netherlands;
• Weller, Michael Laboratory of Molecular Neuro-Oncology, Department of Neurology, and Neuroscience Center Zurich, University Hospital and University of Zurich, Zurich, Switzerland;
• Reardon, David A. Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA;
• Wen, Patrick Y. Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA;

Cancer Research

Oncology